Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord

Experimental Neurology

Volumn 184, Issue 1, 2003, Pages 313-325

  Nakamura, Masaya ^a,b   Houghtling, Richard A ^a,c   MacArthur, Linda ^a   Bayer, Barbara M ^a   Bregman, Barbara S ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b KEIO UNIVERSITY   (Japan)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Cytokine; Inflammatory response; Macrophage; Microglia; Spinal cord injury; TGF

Indexed keywords

CYTOKINE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN DEGENERATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MICROGLIA; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SPINAL CORD INJURY; WHITE MATTER;

EID: 0344826467     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00361-3     Document Type: Article

References (45)

1. Arai K., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines coordinators of immune and inflammatory responses. Annu Rev Biochem. 59:1990;783-836.
2. Bartholdi D., Schwab M. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse an in situ hybridization study. Eur J Neurosci. 9:1997;1422-1438.
3. Basu A., Krady J., O'Malley M., Styren S., DeKosky S., Levison S. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. The Journal of Neuroscience. 22:2002;6071-6082.
4. Bethea J., Nagashima H., Acosta M., Briceno C., Marcillo A., Loor K., Green J., Dietrich W. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. Journal of Neurotrauma. 16:1999;851-863.
5. Bjorklund A. Neural transplantation - an experimental tool with clinical possibilities. Trends Neurosci. 14:1991;319-322.
6. Bregman B. Spinal cord transplants permit the growth of serotonergic axons across the site of neonatal spinal cord transection. Brain Res. 431:1987;265-279.
7. Bregman B. Regeneration in the spinal cord. Curr Opin Neurobiol. 8:1998;800-807.
8. Bregman B., Diener P., McAtee M., Dai H., James C. Intervention strategies to enhance anatomical plasticity and recovery of function after spinal cord injury. Adv Neurol. 72:1997;257-275.
9. Bregman B., Kunkel-Bagden E., Reier P., Dai H., McAtee M., Gao D. Recovery of function after spinal cord injury mechanisms underlying transplant-mediated recovery of function differ after spinal cord injury in newborn and adult rats. Exp Neurol. 123:1993;3-16.
10. Bregman B., Kunkel-Bagden E., Schnell L., Dai H., Gao D., Schwab M. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 378:1995;498-501.
11. Bregman B., McAtee M., Dai H., Kuhn P. Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat. Exp Neurol. 148:1997;475-494.
12. Bregman B., Reier P. Neural tissue transplants rescue axotomized rubrospinal cells from retrograde death. J Comp Neurol. 244:1986;86-95.
13. Bregman, B.S., 1994. Recovery of function after spinal cord injury: transplantation strategies, in: Dunnett, S.B., Bjorklund, A. (Eds.), Functional Neural Transplantation, Raven Press, Ltd. New York, pp. 489-529.
14. Bregman B.S., Bernstein-Goral H., Kunkel-Bagden E. CNS transplants promote-anatomical plasticity and recovery of function after spinal cord injury. Journal of Restorative Neurology and Neuroscience. 2:1991;327-338.
15. Brewer K., Bethea J., Yezierski R. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Experimental Neurology. 159:1999;484-493.
16. Coumans J.V., Lin T.T.-S., Dai H.N., MacArthur L., McAtee M., Nash C., Bregman B.S. Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. J. Neurosci. 21:2001;9334-9344.
17. Dijkstra C., Dopp E., Joling P., Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. Adv Exp Med Biol. 186:1985;409-419.
18. Dusart I., Schwab M. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci. 6:1994;712-724.
19. Finch C., Laping N., Morgan T., Nichols N., Pasinetti G. TGF-beta 1 is an organizer of responses to neurodegeneration. J Cell Biochem. 53:1993;314-322.
20. Franzen R., Schoenen J., Leprince P., Joosten E., Moonen G., Martin D. Effects of macrophage transplantation in the injured adult rat spinal cord a combined immunocytochemical and biochemical study. J Neurosci Res. 51:1998;316-327.
21. Hunter K., Sporn M., Davies A. Transforming growth factor-betas inhibit mitogen-stimulated proliferation of astrocytes. Glia. 7:1993;203-211.
22. Kartje M., Schulz M., Lopez-Yunez A., Schnell L., Schwab M. Corticostriatal plasticity is restricted by myelin-associated neurite growth inhibitors in the adult rat. Ann Neurol. 45:1999;778-786.
23. Kunkel-Bagden E., Dai H., Bregman B. Methods to assess the development and recovery of locomotor function after spinal cord injury in rats. Exp Neurol. 119:1993;153-164.
24. Lacroix S., Chang L., Rose-John S., Tuszynski M. Delivery of hyper-interleukin-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. The Journal of Comparative Neurology. 454:2002;213-228.
25. Lindholm D., Castren E., Kiefer R., Zafra F., Thoenen H. Transforming growth factor-beta 1 in the rat brain increase after injury and inhibition of astrocyte proliferation. J Cell Biol. 117:1992;395-400.
26. Logan A., Berry M. Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol Sci. 14:1993;337-342.
27. Mason J., Suzuki K., Chaplin D., Matsushima G. Interleukin-1 beta promotes repair of the CNS. Journal of Neuroscience. 21:2001;7046-7052.
28. McTigue D., Popovich P., Morgan T., Stokes B. Localization of transforming growth factor-β1 and receptor mRNA after experimental spinal cord injury. Exp Neurol. 163:2000;220-230.
29. Merrill J., Benveniste E. Cytokines in inflammatory brain lesions helpful and harmful. Trends Neurosci. 19:1996;331-338.
30. Merrill J., Zimmerman R. Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF beta. Glia. 4:1991;327-331.
31. Moon L., Fawcett J. Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFbeta1 and beta2. Eur J Neurosci. 14:2001;1667-1677.
32. Morganti-Kossmann M., Kossmann T., Brandes M., Mergenhagen S., Wahl S. Autocrine and paracrine regulation of astrocyte function by transforming growth factor-beta. J Neuroimmunol. 39:1992;163-173.
33. Raineteau O., Z'Graggen W., Thallmair M., Schwab M. Sprouting and regeneration after pyramidotomy and blockade of the myelin-associated neurite growth inhibitors NI 35/250 in adult rats. Eur J Neurosci. 11:1999;1486-1490.
34. Rapalino O., Lazarov-Spiegler O., Agranov E., Velan G., Yoles E., Fraidakis M., Solomon A., Gepstein R., Katz A., Belkin M., Hadani M., Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med. 4:1998;814-821.
35. Reier P., Stokes B., Thompson F., Anderson D. Fetal cell grafts into resection and contusion/compression injuries of the rat and cat spinal cord. Exp Neurol. 115:1992;177-188.
36. Robinson A., White T., Mason D. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology. 57:1986;239-247.
37. Semple-Rowland S., Mahatme A., Popovich P., Green D., Hassler G.J., Stokes B., Streit W. Analysis of TGF-beta 1 gene expression in contused rat spinal cord using quantitative RT-PCR. J Neurotrauma. 12:1995;1003-1014.
38. Streit W., Semple-Rowland S., Hurley S., Miller R., Popovich P., Stokes B. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol. 152:1998;74-87.
39. Theele D., Schrimsher G., Reier P. Comparison of the growth and fate of fetal spinal iso- and allografts in the adult rat injured spinal cord. Exp Neurol. 142:1996;128-143.
40. Toulmond S., Parnet P., Linthorst A. When cytokines get on your nerves cytokine networks and CNS pathologies. Trends Neurosci. 19:1996;409-410.
41. Tyor W., Avgeropoulos N., Ohlandt G., Hogan E. Treatment of spinal cord impact injury in the rat with transforming growth factor-beta. J Neurol Sci. 200:2002;33-41.
42. Vergeli M., mazzanti B., Ballerini C., Gran B., Amaducci L., Massacesi L. Transforming growth factor-beta 1 inhibits the proliferation of rat astrocytes induced by serum and growth factors. J Neurosci Res. 40:1995;127-133.
43. Wenk C., Thallmair M., Kartje G., Schwab M. Increased corticofugal plasticity after unilateral cortical lesions combined with neutralization of the IN-1 antigen in adult rats. J Comp Neurol. 410:1999;143-157.
44. Yao J., Harvath L., Gilbert D., Colton C. Chemotaxis by a CNS macrophage, the microglia. J Neurosci Res. 27:1990;36-42.
45. Z'Graggen W., Metz G., Kartje G., Thallmair M., Schwab M. Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockage of myelin-associated neurite growth inhibitors in adult rats. J Neurosci. 18:1998;4744-4757.